NCT01518101View on ClinicalTrials.gov

Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Type 2 Diabetes
Interventions
DRUG

Vildagliptin/ Metformin

Single pill combination of Vildagliptin/ Metformin (50/1000 mg).

DRUG

Liraglutide

1.2 mg once daily by commercially available injection pens

DRUG

Metformin

1000 mg tablets twice daily

Trial Locations (8)

10115

Novartis Investigative Site, Berlin

13055

Novartis Investigative Site, Berlin

14612

Novartis Investigative Site, Falkensee

44137

Novartis Investigative Site, Dortmund

57290

Novartis Investigative Site, Neunkirchen

66333

Novartis Investigative Site, Völlkingen

66740

Novartis Investigative Site, Saarlouis

01662

Novartis Investigative Site, Meissen

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY